@article{50ef6c42b0d94bfa984d61b07507aab8,
title = "Cost-effectiveness analysis of nivolumab-chemotherapy as first-line therapy for locally advanced/metastatic gastric cancer: a United States payer perspective",
keywords = "cost-effectiveness, gastric cancer, metastatic, nivolumab, trial",
author = "Srujitha Marupuru and Daniel Arku and Axon, \{David R.\} and Lorenzo Villa-Zapata and Mohsen Yaghoubi and Slack, \{Marion K.\} and Terri Warholak",
note = "Publisher Copyright: {\textcopyright} 2023 Informa UK Limited, trading as Taylor \& Francis Group.",
year = "2023",
doi = "10.1080/14737167.2023.2219448",
language = "English",
volume = "23",
pages = "831--841",
journal = "Expert Review of Pharmacoeconomics and Outcomes Research",
issn = "1473-7167",
number = "7",
}